FDA Committee Reviewing Johnson & Johnson COVID-19 Vaccine

The Food and Drug Administration Advisory Committee is expected to approve Johnson & Johnson’s coronavirus vaccine Friday.

This is the last step before the FDA formally grants authorization for the vaccine.

Unlike the two other approved vaccines being used in the U.S., the Johnson & Johnson vaccine only requires one dose.

Johnson & Johnson has agreed to provide 20 million doses by the end of the month and 100 million by June.

Categories: Coronavirus, Coronavirus Cases, Coronavirus Support